Editorial Commentary
Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment
Abstract
A recently published paper by a Stanford research team led by Dr. Joseph C. Liao in Clinical Cancer Research (1) reported on their well-designed study demonstrating the potential application of CD47-targeted near-infrared photoimmunotherapy (NIR-PIT) for human bladder cancer (BC) (Figure 1).
